MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1177/17562848211059954

Медицинская библиотека · Therapeutic advances in gastroenterology · 2021

Tumour necrosis factor inhibitors in inflammatory bowel disease: the story continues.

Peyrin-Biroulet Laurent, Sandborn William J, Panaccione Remo, Domènech Eugeni, Pouillon Lieven, Siegmund Britta, Danese Silvio, Ghosh Subrata

СтатьяОбзорПеревод пока не подготовлен

Аннотация

In the 1990s, tumour necrosis factor-α inhibitor therapy ushered in the biologic therapy era for inflammatory bowel disease, leading to marked improvements in treatment options and patient outcomes. There are currently four tumour necrosis factor-α inhibitors approved as treatments for ulcerative colitis and/or Crohn's disease: infliximab, adalimumab, golimumab and certolizumab pegol. Despite the clear benefits of tumour necrosis factor-α inhibitors, a subset of patients with inflammatory bowel disease either do not respond, experience a loss of response after initial clinical improvement or report intolerance to anti-tumour necrosis factor-α therapy. Optimizing outcomes of these agents may be achieved through earlier intervention, the use of therapeutic drug monitoring and thoughtful switching within class. To complement these approaches, evolving predictive biomarkers may help inform and optimize clinical decision making by identifying patients who might potentially benefit from an alternative treatment strategy. This review will focus on the current use of tumour necrosis factor-α inhibitors in inflammatory bowel disease and the application of personalized medicine to improve future outcomes for all patients.

Для цитирования: Peyrin-Biroulet Laurent, Sandborn William J, Panaccione Remo, Domènech Eugeni, Pouillon Lieven, Siegmund Britta, Danese Silvio, Ghosh Subrata. Tumour necrosis factor inhibitors in inflammatory bowel disease: the story continues.. Therapeutic advances in gastroenterology. 2021. DOI: 10.1177/17562848211059954.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.